Ihe ka njọ nke ọrịa na-egbochi akpa ume na-adịghị ala ala (COPD) bụ ihe mgbaàmà na-akawanye njọ ma ọ bụ ọkụ ọkụ nke nwere ike ịkpata nsonaazụ dị mkpirikpi na ogologo oge. O doro anya na ndị na-arịa ọrịa na-enweghị akụkọ ihe mere eme nwere ike inwe otu ihe na-adịghị mma dị ka ndị na-akọ ha na enwere ike inwe ugboro 2-5 karịa ihe ndị na-enweghị ike ịkọ karịa ndị a kọrọ.
Ngwá ọrụ nnabata COPD Exacerbation (CERT) nke emepụtara ma bụrụ nke GSK, ka emepụtara maka ndị nwere COPD ka ha mata mmalite nke mkpasu iwe wee ghọta mkpa ọ dị ịkọ ndị na-ahụ maka ahụike ha.

CERT na-enye ntụzịaka anya dị mfe maka ndị ọrịa iji nyere ha aka ịmata mgbaàmà ha wee chọọ nlekọta ahụike mgbe achọrọ ha. Ebumnuche bụ ime ka njikwa COPD dị mfe ma melite ogo ndụ maka ndị na-arịa COPD.
Board CERT Governance Board (GB)
Ebumnuche anyị bụ ime ka CERT dị maka ndị na-ege ntị zuru ụwa ọnụ nke ndị ọrịa, ezinụlọ na ndị na-ahụ maka ahụike. Global Allergy na Airways Patient Platform (GAAPP), nche anwụ zuru ụwa ọnụ nke na-enweghị uru nke gụnyere ọtụtụ ụlọ ọrụ na-akwado ndị ọrịa, weghaara ụzọ ọrụ maka GB na Julaị 2024 site na ikike GSK, onye nwe nwebisiinka.
GB ga-elekwasị anya n'ịhụ na CERT iguzosi ike n'ezi ihe sayensị na atụmatụ mmepe ka ọ na-arụ ọrụ na otu ndị ọkachamara sayensị na ahụike mba ụwa gbadoro anya na nkwado, mgbasa ozi, ntụgharị na mmejuputa CERT na omenala dị iche iche.

Ndị otu CERT Governance Board
- Dr. Ruth Tal-Singer, PhD, Board Operations oche
Onye isi ọrụ sayensị
GAAPP, Vienna, Austria - Prọfesọ Paul Jones, Onye isi oche na onye nrụpụta CERT
Dọkịta Nnyocha Kachasị Elu nke GAAPP (Onye Ndụmọdụ)
Prọfesọ Emeritus, City St George's, Mahadum London - Mandeep Moore GPhC, Onye isi ụlọ ọrụ, GSK, UK
- Prọfesọ Toru Oga, Onye ọrụ nyocha agụmakwụkwọ Asia Pacific
Ngalaba ọgwụ iku ume, ụlọ akwụkwọ ahụike Kawasaki
Kurashiki, Okayama, Japan - Dr. Rainer Gloeckl, Phd
Ụlọ ọrụ maka nyocha nyochagharị akpa ume,
Schön Klinik Berchtesgadener Land, Schönau am Königssee, Germany - Nandita Dandekar
Onye nchoputa na onye isi, Pink Tree Foundation,
Pink Tree Health, Mumbai, India.
References
- Jones PW, Lamarca R, Chuecos F, et al. Njiri mara na mmetụta nke mkpasu iwe akuko na enweghị akọ: nsonaazụ sitere na ATTAIN. Eur Respir J. 2014;44(5):1156–1165 . doi: 10.1183/09031936.00038814
- Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Usoro ọgwụgwọ n'oge na-eme ka nsonaazụ dị njọ nke ọrịa na-adịghị ala ala na-egbochi. Am J Respira Crit Care Med. 2004;169 (12):1298–1303 . doi: 10.1164/rccm.200310-1443OC
- Leidy NK, Murray LT, Jones P, Sethi S. Arụmọrụ nke EXAcerbations nke na-adịghị ala ala pulmonary ọrịa ngwá ọrụ ndidi-kọpụtara pụta ihe na atọ clinical ule nke na-adịghị ala ala obstructive pulmonary ọrịa. Ann Am Thorac Soc. 2014;11 (3): 316–325 . doi: 10.1513/AnnalsATS.201309-305OC
- Betsuyaku T, Kato M, Fujimoto K, et al. Nnwale a na-atụghị anya ya nke njikwa dabere na mgbaàmà na ndị ọrịa Japan nwere COPD. Int J Chron Ihe mgbochi Pulmon Dis. 2018;13:2409–2423 . doi: 10.2147/COPD.S152723
- Langsetmo L, Platt RW, Ernst P, Bourbeau J. Na-akọwapụta oke njọ nke ọrịa akwara na-adịghị ala ala na otu ogologo ogologo. Am J Respira Crit Care Med. 2008;177(4):396–401 . doi:
- Jones PW, Wang C, Chen P, Chen L, Wang D, Xia J, Yang Y, Wang Y, Ma Q. Mmepe nke COPD Exacerbation Recognition Tool (CERT) iji nyere ndị ọrịa aka ịmata mgbe ha ga-achọ ndụmọdụ ahụike. Int J Chron Ihe mgbochi Pulmon Dis. 2022 Jan 21;17:213-222 . doi: 10.2147/COPD.S337644. PMID: 35087270; PMCID: PMC8789323.
- Mackay AJ, Donaldson GC, Patel AR, et al. Uru nke nyocha nyocha ọrịa na-adịghị ala ala nke na-egbochi ọrịa akpa ume iji nyochaa ịdị njọ nke COPD njọ. Am J Respira Crit Care Med. 2012;185 (11):1218–1224 . doi: 10.1164/rccm.201110-1843OC.
- Jones PW, Chen WH, Wilcox TK, et al. Ịkọwapụta na ịkọwapụta njirimara mgbaàmà nke COPD exacerbations. Igbe. 2011;139 (6):1388–1394 . doi: 10.1378/obi.10-1240.
- Leidy NK, Wilcox TK, Jones PW, et al. Mmepe nke EXAcerbations nke Ngwá Ọrụ Na-egbochi Ọrịa Pulmonary Na-adịghị Ala Ala (EXACT): ihe nyocha nke onye ọrịa na-akọ (PRO). Uru Health. 2010;13 (8):965–975 . doi: 10.1111/j.1524-4733.2010.00772.x.
- Leidy NK, Wilcox TK, Jones PW, et al. Ịhazi nha nke ọrịa na-adịghị ala ala obstructive pulmonary excerbations. Ntụkwasị obi na nkwado nke akwụkwọ akụkọ onye ọrịa. Am J Respira Crit Care M ed. 2011;183 (3):323–329 . doi: 10.1164/rccm.201005-0762OC.
- Jones, Paul et al. "Mmepe nke Ngwá Ọrụ Nkwukọrịta n'etiti ndị ọrịa na ndị dibịa bekee maka Ịghọta mmejọ COPD na Japan." COPD mp. 20,1 (2023): 216-223. ma ọ bụ: 10.1080 / 15412555.2023.2219742
- Xing, Xiangju et al. "Nkwalite na nyocha ndị ọzọ nke COPD Exacerbation Recognition Tool (CERT)." Usoro iku ume (Carlton, Vic.), 10.1002/resp.70159. 19 Nov. 2025, doi:10.1002/resp.70159
- Wang, Hao et al. "N'ịkwado ka mma nke COPD Exacerbation na ngwaọrụ mkpesa nke onye ọrịa." Usoro iku ume (Carlton, Vic.), 10.1002 / resp.70173. 25 Nov. 2025, doi:10.1002/resp.70173
- Gloeckl, Rainer et al. "Nkụzi onye ọrịa nwere ike iduzi ụzọ? Ntụle isi na isi nke EXACT na CERT maka mmalite nnabata nke nnukwu COPD Exacerbations." Usoro iku ume (Carlton, Vic.), 10.1002/resp.70170. 30 Nov. 2025, doi:10.1002/resp.70170
- Gloeckl R, Tal-Singer R, Deussen P, na ndị ọzọ. Ngwa nchọpụta nke COPD: ntụgharị asụsụ, asụsụ, na nkwenye omenala dị iche iche. Ihe na-adịghị ala ala Pulm Dis. 2026; 13(2): 147-157. doi: http://doi.org/10.15326/jcopdf.2025.0745
Nkwado ego sitere n'aka AstraZeneca, Sanofi, GSK, Boehringer Ingelheim



